The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors for survival in gastric cancer after radical resection: A retrospective study of 1,594 patients in Shanghai.
Yihong Sun
Research Funding - Roche/Genentech
Cong Wang
Research Funding - Roche/Genentech
Zhenbin Shen
Research Funding - Roche/Genentech
Naiqing Zhao
Research Funding - Roche/Genentech
Weidong Chen
Research Funding - Roche/Genentech
Xuefei Wang
Research Funding - Roche/Genentech
Hongshan Wang
Research Funding - Roche
Yong Fang
Research Funding - Roche/Genentech
Fenlin Liu
Research Funding - Roche/Genentech
Zhaoqing Tang
Research Funding - Roche/Genentech
Haojie Li
Research Funding - Roche/Genentech
Chentao Lv
Research Funding - Roche/Genentech
Jing Qin
Research Funding - Roche/Genentech
Yanna Wang
Research Funding - Roche/Genentech
Yongzhe Piao
Employment or Leadership Position - Roche/Genentech
Research Funding - Roche/Genentech
Lisa Wang
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Research Funding - Roche/Genentech
Laura Chu
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Research Funding - Roche/Genentech
Wei Dong
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Research Funding - Roche/Genentech
Xinyu Qin
Research Funding - Roche/Genentech